DCGI approves two clinical trials of indigenous Covid vaccine Corbevax

Daily Current Affairs / DCGI approves two clinical trials of indigenous Covid vaccine Corbevax

Change Language English Hindi

Category : National Published on: September 04 2021

Share on facebook

· The Drug Controller General of India- DCGI has approved two clinical trials of indigenous Covid vaccine Corbevax.

· Vaccine maker Biologicals E has received permission for Phase II and III trials on children between the ages of five and eighteen under certain conditions.

· The Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council – BIRAC have provided support to Biologicals E's COVID-19 Vaccine.

· This support will be provided from the preclinical phase to the third phase of the trial.

Important facts

About the DCGI

v DCGI: Drugs Controller General of India

v Headquarters location: New Delhi

Jul 30

Jul 30

Jul 29

Jul 29

Jul 28

DCGI approves two clinical trials of indigenous Covid vaccine Corbevax

Recent Post's

Notification view all

Jul 30

Jul 30

Jul 29

Jul 29

Jul 28

DCGI approves two clinical trials of indigenous Covid vaccine Corbevax

Recent Post's

Notification
view all